Deb Mathews

Deb Mathews is an experienced professional in the field of medical affairs and strategy, currently serving as the Medical Strategy Lead for Non-Hodgkin Lymphoma at Vaniam Group since May 2020. In addition, Deb Mathews operates Debra Mathews Consulting LLC, offering executive medical affairs strategy consulting to biotech and pharma start-ups since 2013. Deb Mathews has held senior leadership positions in notable companies including CTI BioPharma, Sierra Oncology, Synthetic Biologics, Bayer HealthCare, Novartis, AstraZeneca, Tibotec Therapeutics (Johnson & Johnson Pharmaceuticals), and GlaxoSmithKline, with responsibilities ranging from medical affairs strategy to team management and training development. Deb Mathews holds a Doctor of Pharmacy degree from Florida Agricultural and Mechanical University.